Metabolomics study of biopsy-proven lupus nephritis

Longitudinal study of biopsy-proven Lupus Nephritis patients to identify and validate potential biomarkers using Metabolomics technology

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20230321004

Enrollment

191

Registered

2023-03-21

Start date

2023-05-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lupus nephritis Lupus nephritis

Interventions

biopsy proven lupus nephritis

Basic Science

Lupus nephritis

Eligibility

Sex/Gender

All

Age

18 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. Biopsy proven lupus nephritis 2. eGFR equal to or greater than 15

Exclusion criteria

Exclusion criteria: 1. Lupus nephritis patients taking immunosuppressant due to other medical conditions 2. Lupus nephritis patients also diagnosed with ongoing treatment for infectious diseases or cancers 3. life expectancy less than 1 year

Design outcomes

Primary

Measure	Time frame
lupus nephritis 12 months metabolomics	—

Secondary

Measure	Time frame
disease status 12 months urine analysis	—

Countries

Thailand

Contacts

Public ContactThatsaphan Srithongkul

Mahidol University

thatsaphan.sri@mahidol.ac.th024195505

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026